Please use this identifier to cite or link to this item:
|Title||Assessing Barriers to and Level of Adherence to Hypertension Therapy among Palestinians Living in the Gaza Strip: A Chance for Policy Innovation|
|Title in Arabic||تقييم المعيقات أمام مستوى الالتزام بالعلاج بارتفاع ضغط الدم بين الفلسطينيين الذين يعيشون في قطاع غزة: فرصة للابتكار في السياسات|
Hypertension is a major health concern, especially in low-income countries. Nonadherence and poor or no persistence in adhering to hypertension treatment regimens result in uncontrolled high blood pressure, increasing rates of mortalityandmorbidity,andpreventablehealthcarecosts.Theaimofthisstudywastoassessthelevelofadherenceandbarriersto treatment regimens among hypertensive patients living in the Gaza Strip, Palestine. Methods. A convenience sample of 648 participants completed the Hill-Bone Compliance to High Blood Pressure Therapy Scale. The great majority of participants (n�521, 80.4%) was highly adherent to their treatment regimen, 123 participants (18.98%) were classiﬁed as moderately nonadherent, and 4 (0.62%) participants were classiﬁed as highly nonadherent to their hypertension treatment regimen. Participantsofthisstudyshowedthehighestadherenceratetothedomainofmedicationadherence(meanof1.42outof4)followed byappointmentkeeping(mean1.8),whiletheywereleastadherenttodiet(meanof2.18).Thegreatestthreebarrierstoadherence to the recommended treatment regimen reported by participantswere inability to exercise, inability to resist fast and fried food, and inability to keep themselves away from salty foods. Conclusion. Overall adherence to medication in Gaza was surprisingly good inpatients with a diagnosisof hypertension for atleast one year.However, adherence to lifestyle adviceor dietaryregimes remains poor. A combination of interventions using low-cost mobile technology, combined with face-to-face interventions by healthcare professionals, can be applied to improve adherence to hypertension treatment regimens in order to reduce the consequences of uncontrolled blood pressure.
|Published in||International Journal of Hypertension|
|Item link||Item Link|